Literature DB >> 11939592

The neuronal migration defect in mice with Zellweger syndrome (Pex5 knockout) is not caused by the inactivity of peroxisomal beta-oxidation.

M Baes1, P Gressens, S Huyghe, Nys K De, C Qi, Y Jia, G P Mannaerts, P Evrard, Veldhoven P P Van, P E Declercq, J K Reddy.   

Abstract

The purpose of this study was to investigate whether deficient peroxisomal beta-oxidation is causally involved in the neuronal migration defect observed in Pex5 knockout mice. These mice are models for Zellweger syndrome, a peroxisome biogenesis disorder. Neocortical development was evaluated in mice carrying a partial or complete defect of peroxisomal beta-oxidation at the level of the second enzyme of the pathway, namely, the hydratase-dehydrogenase multifunctional/bifunctional enzymes MFP1/L-PBE and MFP2/D-PBE. In contrast to patients with multifunctional protein 2 deficiency who present with neocortical dysgenesis, impairment of neuronal migration was not observed in the single MFP2 or in the double MFP1/MFP2 knockout mice. At birth, the double knockout pups displayed variable growth retardation and about one half of them were severely hypotonic, whereas the single MFP2 knockout animals were all normal in the perinatal period. These results indicate that in the mouse, defective peroxisomal beta-oxidation does not cause neuronal migration defects by itself. This does not exclude that the inactivity of this metabolic pathway contributes to the brain pathology in mice and patients with complete absence of functional peroxisomes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11939592     DOI: 10.1093/jnen/61.4.368

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  6 in total

1.  Peroxisomal multifunctional protein-2 deficiency causes motor deficits and glial lesions in the adult central nervous system.

Authors:  Steven Huyghe; Henning Schmalbruch; Leen Hulshagen; Paul Van Veldhoven; Myriam Baes; Dieter Hartmann
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

2.  Alterations of fatty acid metabolism and membrane fluidity in peroxisome-defective mutant ZP102 cells.

Authors:  Michiaki Nagura; Makiko Saito; Masao Iwamori; Yoichi Sakakihara; Takashi Igarashi
Journal:  Lipids       Date:  2004-01       Impact factor: 1.880

3.  Cerebral MRI as a valuable diagnostic tool in Zellweger spectrum patients.

Authors:  S Weller; H Rosewich; J Gärtner
Journal:  J Inherit Metab Dis       Date:  2008-04-14       Impact factor: 4.982

4.  Neuronal migration depends on intact peroxisomal function in brain and in extraneuronal tissues.

Authors:  Anneleen Janssen; Pierre Gressens; Markus Grabenbauer; Eveline Baumgart; Arno Schad; Ilse Vanhorebeek; Annelies Brouwers; Peter E Declercq; Dariush Fahimi; Philippe Evrard; Luc Schoonjans; Désiré Collen; Peter Carmeliet; Guy Mannaerts; Paul Van Veldhoven; Myriam Baes
Journal:  J Neurosci       Date:  2003-10-29       Impact factor: 6.167

5.  Deletion of a single allele of the Pex11β gene is sufficient to cause oxidative stress, delayed differentiation and neuronal death in mouse brain.

Authors:  Barbara Ahlemeyer; Magdalena Gottwald; Eveline Baumgart-Vogt
Journal:  Dis Model Mech       Date:  2011-10-04       Impact factor: 5.758

6.  Pathogenesis of peroxisomal deficiency disorders (Zellweger syndrome) may be mediated by misregulation of the GABAergic system via the diazepam binding inhibitor.

Authors:  Rainer Breitling
Journal:  BMC Pediatr       Date:  2004-03-12       Impact factor: 2.125

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.